Drug Profile
Cancer stem cell vaccine - AstraZeneca
Alternative Names: Cancer stem cell-dendritic cell vaccine; CSC-DC vaccineLatest Information Update: 28 May 2020
Price :
$50
*
At a glance
- Originator MedImmune
- Class Cancer vaccines; Dendritic cell vaccines; Stem cell therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 May 2020 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 01 Apr 2017 Pharmacodynamics data from preclinical studies in Cancer presented at the 108th Annual Meeting of the American Association for Cancer Research (AACR-2017)
- 16 Apr 2016 Preclinical trials for Cancer in USA (Parenteral)